你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 项目编号 | 项目主题 | 项目类型 | 项目状态 | 项目持有者 | 提交日期 |
|---|---|---|---|---|---|
| 41713 | CYTOPAK™ GMP HUMAN IL-2 PROTEIN (GMP-L02H14GB01) | II | A | ACROBIOSYSTEMS CO LTD | 2025-03-31 |
| 41711 | AACAS12BMAX ENHANCED, GMP GRADE | II | A | NOVOPROTEIN SCIENTIFIC (HEZE) INC | 2025-03-31 |
| 41709 | HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES | II | A | BEIJING GUOWEI BIOTECHNOLOGY CO LTD | 2025-03-31 |
| 41697 | DEGARELIX ACETATE, NON-STERILE DRUG SUBSTANCE | II | A | HYBIO PHARMACEUTICAL CO LTD | 2025-03-31 |
| 41685 | NK-LIKE T CELL EXOSOMES | II | A | LIAONING MEDICAL DIAGNOSIS & TREATMENT TECHNOLOGY R&D CENTER CO LTD | 2025-03-31 |
| 41649 | 4-ANDROSTENEDIONE | II | A | HUBEI GOTO BIOTECHNOLOGY CO LTD | 2025-03-31 |
| 41647 | Dehydroepiandrosterone | II | A | HUBEI GOTO BIOTECHNOLOGY CO LTD | 2025-03-31 |
| 41643 | TAPINAROF | II | A | METROCHEM API PRIVATE LTD | 2025-03-31 |
| 41638 | DEUCRAVACITINIB INTERMEDIATE-2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)ANILINE | II | A | CHIRAL QUEST (SUZHOU) CO LTD | 2025-03-31 |
| 41602 | PALBOCICLIB | II | A | ALIVUS LIFE SCIENCES LTD | 2025-03-31 |
| 41570 | BRIVARACETAM | II | A | DIVIS LABORATORIES LTD | 2025-03-31 |
| 41518 | RIBOCICLIB SUCCINATE | II | A | ALEMBIC PHARMACEUTICALS LTD | 2025-03-31 |
| 41494 | TRILACICLIB DIHYDROCHLORIDE | II | A | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | 2025-03-31 |
| 41493 | PLECANATIDE | II | A | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | 2025-03-31 |
| 41492 | SELUMETINIB SULFATE | II | A | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | 2025-03-31 |
| 41491 | BRIVARACETAM | II | A | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | 2025-03-31 |
| 41458 | ARIPIPRAZOLE USP | II | A | SURAJ LABORATORIES PRIVATE LTD | 2025-03-31 |
| 41454 | TUCATINIB HEMIETHANOLATE | II | A | DR REDDYS LABORATORIES LTD | 2025-03-31 |
| 41430 | FINNERENONE | II | A | DR REDDYS LABORATORIES LTD | 2025-03-31 |
| 41392 | DINOPROSTONE (IEDA) DRUG SUBSTANCE | II | A | KYOWA PHARMA CHEMICAL CO LTD | 2025-03-31 |
